The DOI matches its Crossref record; 296 of the 296 references it cites were found in a registry or an index.
The role of short-chain fatty acids in microbiota–gut–brain communication
Open accessAbstract
Short-chain fatty acids (SCFAs), the main metabolites produced by bacterial fermentation of dietary fibre in the gastrointestinal tract, are speculated to have a key role in microbiota-gut-brain crosstalk. However, the pathways through which SCFAs might influence psychological functioning, including affective and cognitive processes and their neural basis, have not been fully elucidated. Furthermore, research directly exploring the role of SCFAs as potential mediators of the effects of microbiota-targeted interventions on affective and cognitive functioning is sparse, especially in humans. This Review summarizes existing knowledge on the potential of SCFAs to directly or indirectly mediate microbiota-gut-brain interactions. The effects of SCFAs on cellular systems and their interaction with gut-brain signalling pathways including immune, endocrine, neural and humoral routes are described. The effects of microbiota-targeted interventions such as prebiotics, probiotics and diet on psychological functioning and the putative mediating role of SCFA signalling will also be discussed, as well as the relationship between SCFAs and psychobiological processes. Finally, future directions to facilitate direct investigation of the effect of SCFAs on psychological functioning are outlined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The gut microbiota influences gut barrier and produce neurotransmitters, amino acids and microbial metabolites61.”
From Association between attention-deficit/hyperactivity disorders and intestinal disorders: A systematic review and Meta-analysis (2025) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“gut microbiota dysbiosis has been implicated in behavioral and neurologic pathologies, such as depression, Alzheimer's (AD) and Parkinson's (PD) diseases and autism spectrum disorder (ASD) (9, 21, 25–27).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“brain to gut signaling can directly affect the microbiota, either via immune system or gut functions such as motility, release of neurotransmitters and intestinal immune tone (12, 17, 21, 31).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the gut microbiota can interact with the CNS via gut modulation or directly via metabolites and endotoxin translocation from the lumen to the circulation (9, 17, 21).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“altered SCFA production has been demonstrated in a variety of neuropathologies (19, 21, 33–35).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“these SCFAs regulate the expression levels of tryptophan 5-hydroxylase 1, the enzyme involved in synthesis of serotonin, and tyrosine hydroxylase, which is involved in a rate-limiting step in the biosynthesis of dopamine, noradrenaline and adrenaline; therefore, producing an effect on brain neurochemistry (21, 55, 56, 116, 117).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Microbial metabolites such as short chain fatty acids (SCFAs) exert beneficial effects on psychiatric disorders via the microbiota–gut–brain axis through humoral, hormonal, and immune pathways [12].”
From Effect of Supplementation with Probiotics in Patients with Schizophrenia: Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials (2025) · cites this paper as [12]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“SCFAs exert their physiological activities by acting as endogenous ligands for G-protein-coupled receptors (GPCRs), and modulating gene expression by inhibiting histone deacetylases (HDACs).282”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [282]
The cited source says what the claim attributes to it.
In the citing paper
“SCFAs can modulate the levels of neurotransmitters and neurotrophic factors and regulate the expression of tryptophan 5-hydroxylase, the enzyme involved in the synthesis of serotonin, and tyrosine hydroxylase, the enzyme involved in the rate-limiting step in dopamine, noradrenaline, and adrenaline synthesis (18, 132, 164, 222).”
From Signalling cognition: The gut microbiota and hypothalamic-pituitary-adrenal axis (2023) · cites this paper as [132]
The cited source says what the claim attributes to it.
In the citing paper
“Other pathways through which SCFAs can influence gutbrain communication and brain function include immune, endocrine, neuronal, vagal, and other humoral pathways (360).”
From Diet and the Microbiota–Gut–Brain Axis: Sowing the Seeds of Good Mental Health (2021) · cites this paper as [360]
The cited source says what the claim attributes to it.
In the citing paper
“growing evidence supports the idea that SCFAs also exert crucial physiological effects on several organs, including the brain (17, 20, 21).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]
The cited source says what the claim attributes to it.
In the citing paper
“Accumulating evidence suggests that SCFAs that cross into the CNS have neuroactive properties.”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]
The cited source says what the claim attributes to it.
In the citing paper
“It was described that SCFAs may modulate the levels of neurotransmitters and neurotrophic factors.”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [21]
In the citing paper
“SCFAs are endogenous ligands for a subset of GPCRs, including GPR43 and GPR41, which were subsequently renamed as free fatty acid receptor 2 (FFAR2) and FFAR3, respectively.”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [282]
In the citing paper
“Another important GPCR activated by SCFA is GPR109A, also known as hydroxycarboxylic acid receptor 2 (HCAR2), which is activated by butyrate and β-D-hydroxy butyrate.282”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [282]
In the citing paper
“and intracellular SCFAs can influence gene expression via histone deacetylation (HDAC) inhibition (Dalile et al., 2019)”
From The modulatory effects of gut microbes and metabolites on blood-brain barrier integrity and brain function in sepsis-associated encephalopathy (2023) · cites this paper as Dalile et al., 2019
In the citing paper
“Moreover, SCFAs are endogenous ligands of orphan G protein-coupled receptors (GPCRs)”
From The modulatory effects of gut microbes and metabolites on blood-brain barrier integrity and brain function in sepsis-associated encephalopathy (2023) · cites this paper as Dalile et al., 2019
In the citing paper
“Altered SCFA production has also been demonstrated in a variety of neuropathologies (42, 116, 127, 130, 132, 292–295).”
From Signalling cognition: The gut microbiota and hypothalamic-pituitary-adrenal axis (2023) · cites this paper as [132]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100
From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites
Koh, A., De Vadder, F., Kovatcheva-Datchary, P., & Bäckhed, F. (2016) · Cell · doi:10.1016/j.cell.2016.05.041 · Cited by 7,070
Gibson, G. R., Hutkins, R., Sanders, M. E., Prescott, S. L., Reimer, R. A., Salminen, S. J., Scott, K., Stanton, C., Swanson, K. S., Cani, P. D., et al. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.75 · Cited by 5,634
Self-citationCommensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
Cryan, J. F., & Dinan, T. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3346 · Cited by 4,572
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942
Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102999108 · Cited by 3,888
Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease
Sampson, T. R., Debelius, J. W., Thron, T., Janssen, S., Shastri, G. G., Ilhan, Z. E., Challis, C., Schretter, C. E., Rocha, S., Gradinaru, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.018 · Cited by 3,622
Cited by
Sorted by citations
Items 801–900 of 1,008
The role of the gut microbiota in depressive-like behavior induced by chlorpyrifos in mice
Sun, Y., Pei, J., Chen, X., Lin, M., Pan, Y., Zhang, Y., Bai, W., Zhou, X., & Zhang, W. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.114470 · Cited by 36
Assessment of Microbiota in the Gut and Upper Respiratory Tract Associated with SARS-CoV-2 Infection
Li, J., Jing, Q., Li, J., Hua, M., Di, L., Song, C., Huang, Y., Wang, J., Chen, C., & Wu, A. R. (2020) · Microbiome · doi:10.1186/s40168-022-01447-0 · Cited by 36
Lee, J., Lee, G., Ko, G., & Lee, S. J. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.03.005 · Cited by 36
Li, Z., Qing, Y., Cui, G., Li, M., Liu, T., Zeng, Y., Zhou, C., Hu, X., Jiang, J., Wang, D., et al. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.03.005 · Cited by 36
Gut dysbiosis in autoimmune diseases: Association with mortality
Chang, S.-H., & Choi, Y. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1157918 · Cited by 36
Bacillus licheniformis prevents and reduces anxiety-like and depression-like behaviours
Feng, S., Chen, M., Liu, Y., Yi, Y., Liang, A., Zhang, Y., & Hao, Z. (2023) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-023-12580-7 · Cited by 36
Borghi, E., & Vignoli, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174160 · Cited by 36
Seven facts and five initiatives for gut microbiome research
Li, D., Gao, C., Zhang, F., Yang, R., Lan, C., Ma, Y., & Wang, J. (2020) · Protein & Cell · doi:10.1007/s13238-020-00697-8 · Cited by 36
Immunotherapy and Microbiota for Targeting of Liver Tumor-Initiating Stem-like Cells
Machida, K., & Tahara, S. M. (2022) · Cancers · doi:10.3390/cancers14102381 · Cited by 35
Zampieri, G., Efthimiou, G., & Angione, C. (2023) · Metabolic Engineering · doi:10.1016/j.ymben.2023.01.008 · Cited by 35
Gut-muscle axis and sepsis-induced myopathy: The potential role of gut microbiota
Liu, Y., Xu, L., Yang, Z., Wang, D., Li, T., Yang, F., Li, Z., Bai, X., & Wang, Y.-C. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114837 · Cited by 34
The gut microbes in inflammatory bowel disease: Future novel target option for pharmacotherapy
Yuan, S., Wang, K.-S., Meng, H., Hou, X.-T., Xue, J.-C., Liu, B., Cheng, W., Li, J., Zhang, H., Nan, J., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114893 · Cited by 35
Singh, S. V., Ganguly, R., Jaiswal, K., Yadav, A. K., Kumar, R., & Pandey, A. K. (2023) · World Journal of Clinical Cases · doi:10.12998/wjcc.v11.i19.4458 · Cited by 36
Hui, H., Wang, Z., Zhao, X., Xu, L., Yin, L., Wang, F., Qu, L., & Peng, J. (2023) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2023.08.003 · Cited by 35
Attention Deficit Hyperactivity Disorder (ADHD) and the gut microbiome: An ecological perspective
Cickovski, T., Mathee, K., Aguirre, G., Tatke, G., Hermida, A., Narasimhan, G., & Stollstorff, M. (2023) · PLoS ONE · doi:10.1371/journal.pone.0273890 · Cited by 35
Niu, M., Guo, H.-X., Cai, J.-W., Duan, B., Chen, Y., & Xiang-chen, M. (2023) · Food Bioscience · doi:10.1016/j.fbio.2023.103020 · Cited by 35
He, X., Guo, J., Shen, J. F., Jiang, S., Han, S., & Li, L. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122188 · Cited by 35
Koutromanos, I., Legaki, E., Gazouli, M., Vasilopoulos, E., Kouzoupis, A. V., & Tzavellas, E. (2024) · World Journal of Methodology · doi:10.5662/wjm.v14.i1.88519 · Cited by 35
Riva, A., Şahin, E., Volpedo, G., Petretto, A., Lavarello, C., Sapia, R. D., Barbarossa, D., Zaniani, N. R., Craparotta, I., Barbera, M. C., et al. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106469 · Cited by 35
Luo, X., Liu, Y., Balck, A., Klein, C., & Fleming, R. M. T. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00732-z · Cited by 35
Gut microbiome and metabolic pathways linked to sleep quality
Seong, H. J., Baek, Y., Lee, S., & Jin, H. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1418773 · Cited by 35
Gut redox and microbiome: charting the roadmap to T-cell regulation
Prasad, S., Singh, S., Menge, S., Mohapatra, I., Kim, S., Helland, L. C., Singh, G., & Singh, A. R. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1387903 · Cited by 35
Palepu, M. S. K., Bhalerao, H. A., Sonti, R., & Dandekar, M. P. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176960 · Cited by 35
Kelly, C. A., Trumpff, C., Acosta, C., Assuras, S., Baker, J., Basarrate, S., Behnke, A., Bo, K., Bobba‐Alves, N., Champagne, F. A., et al. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.08.006 · Cited by 35
Yao, Z., Cao, Y.-N., Peng, L., Yan, Z., & Zhao, G. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c05691 · Cited by 35
Sex-Dependent Effects of Intestinal Microbiome Manipulation in a Mouse Model of Alzheimer’s Disease
Kaur, H., Nookala, S., Singh, S., Mukundan, S., Nagamoto‐Combs, K., & Combs, C. K. (2021) · Cells · doi:10.3390/cells10092370 · Cited by 35
Fabersani, E., Marquez, A., Russo, M., Ross, R., Torres, S., Fontana, C. A., Puglisi, E., Medina, R. B., & Gauffin-Cano, P. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.718564 · Cited by 35
Wang, Q., Davis, P. B., Qi, X., Chen, S. G., Gurney, M. E., Perry, G. L., Doraiswamy, P. M., & Xu, R. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00917-1 · Cited by 35
Lanza, M., Filippone, A., Casili, G., Giuffrè, L., Scuderi, S. A., Paterniti, I., Campolo, M., Cuzzocrea, S., & Esposito, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094847 · Cited by 35
Choi, B. S.-Y., Brunelle, L., Pilon, G., Cautela, B. V. G., Tompkins, T. A., Drapeau, V., Marette, A., & Tremblay, A. (2022) · Nutritional Neuroscience · doi:10.1080/1028415x.2022.2081288 · Cited by 35
Zhang, X., Zhang, B., Peng, B., Wang, J., Hu, Y., Wang, R., & Wang, S. (2022) · Nutrients · doi:10.3390/nu14132765 · Cited by 35
Fucoidan ameliorates LPS-induced neuronal cell damage and cognitive impairment in mice
Wang, Y., Wang, Q., Duan, L., Li, X., Yang, W., Huang, T., Kong, M., Guan, F., & Ma, S. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.09.231 · Cited by 35
Zhou, C., Gong, S.-Z., Xiang, S., Liang, L., Hu, X., Huang, R., Liao, Z., Ma, Y., Xiao, Z., & Qiu, J. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.965471 · Cited by 36
Ferroptosis is a new therapeutic target for spinal cord injury
Bai, X., Liu, X., Deng, Z.-Z., Wei, D.-M., Zhang, D., Xi, H.-L., Wang, Q.-Y., He, M.-Z., & Yang, Y.-L. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1136143 · Cited by 36
Zahedi, E., Sadr, S. S., Sanaeierad, A., & Roghani, M. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114848 · Cited by 35
Meckel, K. R., Simpson, S., Godino, A., Peck, E. G., Sens, J. P., Leonard, M. Z., George, O., Calipari, E. S., Hofford, R. S., & Kiraly, D. D. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01661-w · Cited by 35
Wauters, L., Van Oudenhove, L., Accarie, A., Geboers, K., Geysen, H., Toth, J., Luypaerts, A., Verbeke, K., Smokvina, T., Raes, J., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2031695 · Cited by 34
Self-citationZhang, Y., Xu, S., Qian, Y., He, X., Mo, C., Yang, X., & Xiao, Q. (2022) · Brain Research · doi:10.1016/j.brainres.2021.147749 · Cited by 34
Fang, Z., Li, L., Lu, W., Zhao, J., Zhang, H., Lee, Y. K., & Chen, W. (2020) · Food Bioscience · doi:10.1016/j.fbio.2020.100648 · Cited by 34
Gut microbiota: A new target for traditional Chinese medicine in the treatment of depression
Li, B., Xu, M., Wang, Y., Feng, L., Xing, H., & Zhang, K. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.116038 · Cited by 35
Chen, S., Yang, J.-L., Zhang, Y.-S., Wang, H., Lin, X.-Y., Xue, R.-Y., Li, M., Li, S., Juhasz, A. L., Ma, L. Q., et al. (2023) · Environmental Pollution · doi:10.1016/j.envpol.2023.121376 · Cited by 34
The associations of gut microbiota, endocrine system and bone metabolism
Tu, Y., Kuang, X., Zhang, L., & Xu, X. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1124945 · Cited by 34
Cracking Brain Diseases from Gut Microbes-Mediated Metabolites for Precise Treatment
Gong, Y., Chen, A., Zhang, G., Shen, Q., Zou, L., Li, J., Miao, Y., & Liu, W. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.85259 · Cited by 34
The role of gut microbiota in the pathogenesis and treatment of postpartum depression
Zhang, S., Lu, B., & Wang, G. (2023) · Annals of General Psychiatry · doi:10.1186/s12991-023-00469-8 · Cited by 34
Huang, Y., Liu, F., Lai, J., Jiang, S., Tan, X., Chen, L., Xu, Y., Xiong, X., & Deng, Y. (2024) · Journal of Dermatological Treatment · doi:10.1080/09546634.2023.2299107 · Cited by 34
Meng, Q., Guo, J., Lv, K., Liu, Y., Zhang, J., Li, M., Cheng, X., Chen, S., Huo, X., Zhang, Q., et al. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.02.020 · Cited by 34
Gut microbiome-metabolites axis: A friend or foe to colorectal cancer progression
Wu, H., Ma, W., Wang, Y., Wang, Y., Sun, X., & Zheng, Q. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116410 · Cited by 34
Human Breast Milk: The Role of Its Microbiota and Metabolites in Infant Health
Zhang, M., Qiao, H., Yang, S., Kwok, L., Zhang, H., & Zhang, W. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c07690 · Cited by 34
Xiao, H., Wang, Y., Chen, Y., Chen, R., Yang, C., Geng, B., & Xia, Y. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1419566 · Cited by 34
The Gut Microbiome-Neuroglia Axis: Implications for Brain Health, Inflammation, and Disease
Camberos-Barraza, J., Guadrón‐Llanos, A. M., & la Herrán-Arita, A. K. D. (2024) · Neuroglia · doi:10.3390/neuroglia5030018 · Cited by 34
Moshfeghinia, R., Nemati, H., Ebrahimi, A., Shekouh, D., Karami, S., Eraghi, M. M., Mohagheghzadeh, H., Hunter, J., & Pasalar, M. (2025) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2025.05.053 · Cited by 34
Prebiotics and Gut Health: Mechanisms, Clinical Evidence, and Future Directions
Monteiro, C. R. A. V., Bogéa, E. G., Campos, C. D. L., Filho, J. L. P., Almeida, V. S. S., Vale, A. Á. M., de Azevedo-Santos, A. P. S., & Monteiro‐Neto, V. (2026) · Nutrients · doi:10.3390/nu18030372 · Cited by 36
Li, K.-M., Wang, L., Wong, C. Y., Chiu, P. K., Teoh, J. Y., Kwok, H. S., Leung, S. C. H., Wong, S. H., Tsui, S. K., & Ng, C. (2021) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-021-00360-1 · Cited by 34
Postoperative pain and the gut microbiome
Brenner, D., Shorten, G., & O’Mahony, S. M. (2021) · Neurobiology of Pain · doi:10.1016/j.ynpai.2021.100070 · Cited by 34
The Role of Butyric Acid in Treatment Response in Drug-Naïve First Episode Schizophrenia
Li, X., Fan, X., Yuan, X., Pang, L., Hu, S., Wang, Y., Huang, X., & Song, X. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.724664 · Cited by 34
Neuroprotective Potential of Non-Digestible Oligosaccharides: An Overview of Experimental Evidence
Divyashri, G., Sadanandan, B., Murthy, K. N. C., Shetty, K., & Mamta, K. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.712531 · Cited by 34
Decoding microbial genomes to understand their functional roles in human complex diseases
Wang, Y., Dong, Q., Hu, S., Zou, H., Wu, T., Shi, J., Zhang, H., Sheng, Y., Sun, W., Kong, X., et al. (2022) · iMeta · doi:10.1002/imt2.14 · Cited by 34
Luo, D., Yang, L., Pang, H., Zhao, Y., Li, K., Rong, X., & Guo, J. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.984019 · Cited by 34
Short-chain fatty acids–microbiota crosstalk in the coronavirus disease (COVID-19)
Włodarczyk, J., Czerwiński, B., & Fichna, J. (2022) · Pharmacological Reports · doi:10.1007/s43440-022-00415-7 · Cited by 34
Identification of Gut Microbiota Affecting Fiber Digestibility in Pigs
Niu, Q., Pu, G., Fan, L., Chen, G., Lan, T., Liu, C., Du, T., Kim, S. W., Niu, P., Zhang, Z., et al. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44100312 · Cited by 34
Intestinal Flora Affect Alzheimer's Disease by Regulating Endogenous Hormones
Wu, Y., Hang, Z., Tong, L., & Du, H. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03784-w · Cited by 34
Interplay between Gut Microbiota and NLRP3 Inflammasome in Intracerebral Hemorrhage
Zhang, Y., Yu, W., Flynn, C., Chang, W., Zhang, L., Wang, M., Zheng, W., & Li, P. (2022) · Nutrients · doi:10.3390/nu14245251 · Cited by 34
Walden, K. E., Moon, J. M., Hagele, A. M., Allen, L. E., Gaige, C. J., Krieger, J. M., Jäger, R., Mumford, P. W., Pane, M., & Kerksick, C. M. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1219313 · Cited by 35
Targeting gut-liver axis by dietary lignans ameliorate obesity: evidences and mechanisms
Chu, Z., Hu, Z., Luo, Y., Zhou, Y., Yang, F., & Luo, F. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2272269 · Cited by 35
Molecular Aspects of MAFLD—New Insights on Pathogenesis and Treatment
Filipović, B. F., Marjanovic-Haljilji, M., Mijac, D. D., Lukić, S., Kapor, S., Kapor, S., Starčević, A., Popovic, D. D., & Djoković, A. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45110573 · Cited by 34
Crosstalk Between the Gut and Brain: Importance of the Fecal Microbiota in Patient With Brain Tumors
Li, Y., Jiang, H., Wang, X., Liu, X., Huang, Y., Wang, Z., Ma, Q., Dong, L., Qi, Y., Zhang, H., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.881071 · Cited by 33
Tian, D., Xu, W., Pan, W., Zheng, B., Yang, W., Jia, W., Liu, Y., Garstka, M. A., Gao, Y., & Yu, H. (2022) · The EMBO Journal · doi:10.15252/embj.2022111139 · Cited by 33
The gut microbiota and metabolite profiles are altered in patients with spinal cord injury
Kong, G., Zhang, W., Zhang, S., Chen, J., He, K., Zhang, C., Yuan, X., & Xie, B. (2023) · Molecular Brain · doi:10.1186/s13041-023-01014-0 · Cited by 33
Al-Marzooqi, S. K., Almarzooqi, F., Sadida, H. Q., Jerobin, J., Ahmed, I., Abou‐Samra, A., Fakhro, K. A., Dhawan, P., Bhat, A. A., & Akil, A. A. (2024) · Obesity Reviews · doi:10.1111/obr.13766 · Cited by 33
Host–microbe interactions: communication in the microbiota–gut–brain axis
Shekarabi, A., Qureishy, I., Puglisi, C. H., Dalseth, M., & Vuong, H. E. (2024) · Current Opinion in Microbiology · doi:10.1016/j.mib.2024.102494 · Cited by 36
Deng, L., & Tan, K. S. W. (2025) · The Lancet Microbe · doi:10.1016/j.lanmic.2025.101155 · Cited by 33
Zhu, J., Fu, Y., Olovo, C. V., Xu, J., Wu, Q., Wei, W., Jiang, K., & Zheng, X. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1535356 · Cited by 33
Taj, T., Kaushik, M., Islam, A., Das, J., Kumar, B., Hussain, M. S., Ramzan, M., Ashique, S., Tariq, M., Sridhar, S. B., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118861 · Cited by 35
Liu, W., Tang, S., Zhao, Q., Zhang, W., Li, K., Yao, W., & Gao, X. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.01.303 · Cited by 33
Gut–Brain Axis: Focus on Neurodegeneration and Mast Cells
Conte, C., Sichetti, M., & Traina, G. (2020) · Applied Sciences · doi:10.3390/app10051828 · Cited by 33
The Protective and Long-Lasting Effects of Human Milk Oligosaccharides on Cognition in Mammals
Docq, S., Spoelder, M., Wang, W., & Homberg, J. R. (2020) · Nutrients · doi:10.3390/nu12113572 · Cited by 33
Nutrition and cognition across the lifetime: an overview on epigenetic mechanisms
Polverino, A., Sorrentino, P., Pesoli, M., & Mandolesi, L. (2021) · AIMS neuroscience · doi:10.3934/neuroscience.2021024 · Cited by 33
Xi, Y., Li, H., Yu, M., Li, X., Li, Y., Hui, B., Zeng, X., Wang, J., & Li, J. (2021) · Food & Function · doi:10.1039/d1fo03334d · Cited by 33
Rangarajan, A. A., Chia, H. E., Azaldegui, C. A., Olszewski, M., Pereira, G. V., Koropatkin, N. M., & Biteen, J. S. (2022) · Microbiology · doi:10.1099/mic.0.001180 · Cited by 33
Nakajima, H., Nakanishi, N., Miyoshi, T., Okamura, T., Hashimoto, Y., Senmaru, T., Majima, S., Ushigome, E., Asano, M., Yamaguchi, M., et al. (2022) · Nutrition & Metabolism · doi:10.1186/s12986-022-00685-1 · Cited by 33
Marć, M. A., Jastrząb, R., & Mytych, J. (2022) · Nutrients · doi:10.3390/nu14193967 · Cited by 33
The Role of a Colon-in-Continuity in Short Bowel Syndrome
Verbiest, A., Jeppesen, P. B., Joly, F., & Vanuytsel, T. (2023) · Nutrients · doi:10.3390/nu15030628 · Cited by 33
Tsuji, A., Yoshikawa, S., Ikeda, Y., Taniguchi, K., Sawamura, H., Morikawa, S., Nakashima, M., Asai, T. T., & Matsuda, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065465 · Cited by 33
Liu, D., Zhuang, B. A., Wei, M., Yuan, T., Li, J., Deng, P., Du, L., Yuan, B., & Jin, Y. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.124402 · Cited by 33
Cytoprotection of probiotics by nanoencapsulation for advanced functions
Zhang, T., Shang, C., Du, T., Zhuo, J., Wang, C., Li, B., Xu, J., Fan, M., Wang, J., & Zhang, W. (2023) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2023.104227 · Cited by 33
Volatiana, J. A., Wang, L., Gray, N., Tong, S., Zhang, G., & Shao, Q. (2019) · Aquaculture Research · doi:10.1111/are.14355 · Cited by 33
Narrative review on potential role of gut microbiota in certain substance addiction
Qin, C., Hu, J., Wan, Y., Cai, M., Wang, Z., Peng, Z., Liao, Y., Li, D., Yao, P., Liu, L., et al. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110093 · Cited by 32
Duan, H., Hu, J., Deng, Y., Zou, J., Ding, W., Peng, Q., Duan, R., Sun, J., & Zhu, J. (2023) · Nutrients · doi:10.3390/nu16010009 · Cited by 32
Zhang, Y., Li, L., Sun, S., Cheng, L., Gu, Z., & Hong, Y. (2024) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2024.121825 · Cited by 32
Nie, M., Li, J., Lin, R., Gong, X., Dang, B., Zhang, W., Yang, X., Wang, L., Wang, F., & Tong, L. (2024) · Food Research International · doi:10.1016/j.foodres.2024.114355 · Cited by 32
Adamberg, S., & Adamberg, K. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e31134 · Cited by 32
Xiao, X., Cui, T., Qin, S., Wang, T., Liu, J., Sa, L., Wu, Y., Zhong, Y., & Yang, C. (2024) · Poultry Science · doi:10.1016/j.psj.2024.104280 · Cited by 32
Zhang, Q., Zhao, W., Yun, Y., Ma, T., An, H., Fan, N., Wang, J., Wang, Z., & Yang, F. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.12.070 · Cited by 32
Interkingdom signaling between gastrointestinal hormones and the gut microbiome
Zhao, X., Qiu, Y., Liang, L., & Fu, X. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2456592 · Cited by 33
How the gut microbiota impacts neurodegenerative diseases by modulating CNS immune cells
Schaible, P., Henschel, J., & Erny, D. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03371-0 · Cited by 32
Bedarf, J. R., Romano, S., Heinzmann, S. S., Duncan, A., Τράκα, Μ., Ng, D. Y. K., Segovia-Lizano, D., Simon, M., Narbad, A., Wüllner, U., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-00885-5 · Cited by 32
Sarcopenia in Parkinson's disease: from pathogenesis to interventions
Gui, M., Lv, L., Hu, S., Qin, L., & Wang, C. (2025) · Metabolism · doi:10.1016/j.metabol.2025.156272 · Cited by 34
Microbial regulation of microRNA expression in the brain–gut axis
Moloney, G. M., Dinan, T. G., Clarke, G. A., & Cryan, J. F. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.08.005 · Cited by 32
Gut microbiota in surgical and critically ill patients
Ho, K. M., Kalgudi, S., Corbett, J.-M., & Litton, E. (2020) · Anaesthesia and Intensive Care · doi:10.1177/0310057x20903732 · Cited by 32
Gut-microbiota-directed strategies to treat epilepsy: clinical and experimental evidence
Granados, D. M. M., Villasana‐Salazar, B., Lozano‐García, L., Cavalheiro, É. A., & Striano, P. (2021) · Seizure · doi:10.1016/j.seizure.2021.03.009 · Cited by 32
Metadata
- Authors
- Dalile, B., Van Oudenhove, L., Vervliet, B., & Verbeke, K.
- Affiliations
- KU Leuven (BE)
- Corresponding author
- Verbeke, Kristin
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2019-05-23
- Volume
- 16
- Issue
- 8
- Pages
- 461-478
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W2946372752
- Cited by
- 3,357
- References
- 289
- Citations by year
- 2026: 631 · 2025: 685 · 2024: 567 · 2023: 511 · 2022: 429 · 2021: 334 · 2020: 174 · 2019: 25
- FWCI
- 21.30
- Type
- journal article
- Language
- en
- Open access
- green
- lirias.kuleuven.be
- Licence
- Locations
- Nature Reviews Gastroenterology & Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Lirias (submittedVersion, other-oa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- short-chain fatty acids, microbiota-gut-brain axis, dietary fiber fermentation, gut microbiota, psychological functioning, emotional processing, cognitive processes, prebiotics, probiotics, microbiota-targeted interventions, immune signaling, hormone signaling, psychobiology
- MeSH terms
- Gastrointestinal Microbiome, Animals, Mental Disorders, Brain, Dietary Fiber, Disease Models, Animal, Fatty Acids, Volatile, Humans, Neural Pathways, Signal Transduction, Gastrointestinal Tract
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
